International Space Station– tag –
-
Private Firms Step Up Microgravity Drug R&D and Develop Commercial Space Stations as ISS Deorbit Nears
PharmaVoice USA Overview As the International Space Station (ISS) approaches deorbit, private companies are taking the lead to continue microgravity drug research and development (R&D). Despite the proven success of over a decade of ... -
Exobiosphere Secures €3M Seed for March 2027 Microgravity Drug Discovery Mission Aboard Vast’s Haven-1
Forbes Luxembourg ルクセンブルク Overview Luxembourgish startup Exobiosphere has successfully raised €3 million in seed funding for its inaugural microgravity drug discovery mission. Scheduled for March 2027 on Vast's Haven-1 commercial ... -
ISS National Lab Drives Breakthroughs in Disease Modeling, Regenerative Medicine, and Materials Production Through Microgravity Research
ISS National Lab USA Overview The International Space Station (ISS) National Lab is propelling significant advancements in diverse fields such as disease modeling, tissue engineering, therapeutic development, and materials production thr... -
ISS Microgravity Accelerates Stem Cell 3D Tissue Growth, Unlocking Breakthroughs in Cancer Treatment and Regenerative Medicine
The Economic Times India Overview International Space Station (ISS) microgravity research reveals that stem cells grow into more realistic 3D tissue structures faster than on Earth, offering profound insights for cancer treatment and reg...
